Nelson Leung

Edith Cowan University — Australia

Biochemistry, Genetics and Molecular Biology · Life Sciences

93h-index36.0kcitations1.0kworks2.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Amyloidosis: Diagnosis, Treatment, Outcomes(462), Multiple Myeloma Research and Treatments(379), Renal Diseases and Glomerulopathies(164), Chronic Lymphocytic Leukemia Research(107), Protein Degradation and Inhibitors(103)

Publications1.0k total

Management of monoclonal gammopathy of renal significance: treatment standard
Nephrology Dialysis Transplantation·2025
Efficacy and Safety of Varied Bisphosphonate Therapy Dosing in Patients With Hypercalcemia of Malignancy
JCO Oncology Practice·2025
Prognostic value of immunoparesis, lymphopenia, high serum ferritin, and suppression of the non-involved serum free light chains (niFLC) in relapsed and refractory multiple myeloma patients (RRMM) receiving bispecific antibodies
Blood·2025Open Access
Real-world (RW) outcomes of newly diagnosed multiple myeloma (NDMM) patients (pts) treated with front-line daratumumab (dara), bortezomib (bor), lenalidomide (len) and dexamethasone (dex) (DVRd)
Blood·2025
Cytogenetics-based clinical trajectories of patients with MRD negativity post autologous stem cell transplant for multiple myeloma
Blood·2025
Genetic evolution of Waldenström macroglobulinemia across disease stages
Blood·2025Open Access
Disease characteristics, treatment patterns, and outcomes of AL amyloidosis patients with high-risk FISH cytogenetics
Blood·2025
Parameters Associated With Renal Recovery and Survival in Myeloma Patients With Acute Renal Failure to Cast Nephropathy
American Journal of Hematology·2025· 2 citedOpen Access
AL amyloidosis: a real-world experience with CAR T-cell therapy
Blood Advances·2025Open Access
Clinical Characteristics, Treatment Responses and Outcomes of Light Chain Multiple Myeloma
American Journal of Hematology·2025
A collaborative approach to amyloidosis and a multidisciplinary care framework – position statement from the International Society of Amyloidosis
Amyloid·2025
Kidney Organoid Model of Light Chain Amyloidosis
Journal of the American Society of Nephrology·2025
Is F18-FDG PET-CT a Reliable Diagnostic Tool for Immune Checkpoint Inhibitor-Associated Acute Interstitial Nephritis?
Journal of the American Society of Nephrology·2025
Plasma Exchange for the Treatment of Light Chain Cast Nephropathy: A Multicenter Study
Journal of the American Society of Nephrology·2025
Detection of FGA c.1634A>T (p.E545V) in Residual Paraffin-Embedded Kidney Biopsies in Fibrinogen Alpha Amyloidosis: Proof-of-Concept
Journal of the American Society of Nephrology·2025
Current experiences with teclistamab in patients with multiple myeloma and renal impairment
Expert Review of Hematology·2025· 2 cited
Refining PET-based response in extramedullary multiple myeloma using total lesion glycolysis
Leukemia·2025
From adoption to social sustainability: examining the factors affecting students’ use of virtual reality in higher education
Education and Information Technologies·2025· 1 cited
Outcomes of CAR-T Cell Therapy in Patients with AL Amyloidosis
Clinical Lymphoma Myeloma & Leukemia·2025
Performance of Deauville Score and Total Lesion Glycolysis as Response Markers for Multiple Myeloma with Extramedullary Disease
Clinical Lymphoma Myeloma & Leukemia·2025
page 1 of 51Next →

Frequent Co-authors

Angela Dispenzieri(22), S. Vincent Rajkumar(19), Morie A. Gertz(19), Robert A. Kyle(18), Sanjeev Sethi(18), Fernando C. Fervenza(17), Shaji Kumar(16), Samih H. Nasr(16), Martha Q. Lacy(14), Francis K. Buadi(14), David Dingli(12), Suzanne R. Hayman(12), Stephen J. Russell(11), John A. Lust(10), Lynn D. Cornell(10), Mary E. Fidler(8), Prashant Kapoor(7), Steven R. Zeldenrust(7), Frank Bridoux(6), Yi Lin(6)